Unstable angina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Volunteer to participate in the trial and sign the informed consent; 2. Age between 30 and 75 (including 30 and 75); 3. It meets the diagnostic criteria for unstable angina pectoris; 4. Patients with angina pectoris for at least 2 times within 10 days before enrollment; 5. Unstable angina pectoris, Braunwald grade I.
Exclusion criteria
Exclusion criteria: 1. Patients who need revascularization and/or are willing to undergo revascularization as determined by the investigator; 2. Patients with resting angina pectoris 48 hours before enrollment; 3. Chest pain caused by diseases other than coronary artery disease, such as severe neurosis, hyperthyroidism, cholecardiac syndrome, gastric and esophageal reflux, aortic dissection, etc.; 4. NYHA cardiac function grade III, IV; Left ventricular ejection fraction (LVEF) and the normal upper limit of serum creatinine (SCR) BBB> 7. People with bleeding tendency; 8. Previous history of hemorrhagic disease, or current concurrent hemorrhagic disease; 9. Other factors affecting the evaluation of total load of ischemic myocardium, such as cardiac hypertrophy, left bundle branch block, digitalis, electrolyte disturbance, etc.; 10. Those who had taken traditional Chinese medicine for coronary heart disease or angina pectoris within 1 week before inclusion and had the effects of promoting qi, promoting blood circulation and removing blood stasis; 11. People with allergic constitution or known allergy to the test drug; 12. A history of mental illness or drug or alcohol abuse; 13. Women who are pregnant or lactating, or have a family planning plan during the study period; 14. Participating in clinical trials of other drugs within the last 3 months; 15. The investigator considers it inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of angina attacks on day 10 changed from baseline; | — |
Countries
China